Analyst Ratings for Cellectis (CLLS) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2022 | Baird | Madhu Kumar | Upgrade | Outperform (Neutral) |
10.00 (N/A) |
3.48 (2.62) |
-24.71% | Details |
| 11/30/2021 | JMP Securities » Updated 1/19/2023 |
Silvan Tuerkcan | New Coverage | Market Outperform (N/A) |
6.00 (11.00) |
8.69 (2.62) |
-69.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
